Olanzapine and Ligament sprain - a phase IV clinical study of FDA data

Summary:

Ligament sprain is reported as a side effect among people who take Olanzapine (olanzapine), especially for people who are female, 20-29 old, have been taking the drug for 1 - 6 months also take Abilify, and have Cataplexy.

The phase IV clinical study analyzes which people have Ligament sprain when taking Olanzapine. It is created by eHealthMe based on reports of 68,588 people who have side effects when taking Olanzapine from the FDA, and is updated regularly.

What is Olanzapine?

Olanzapine has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 69,242 Olanzapine users. Check the latest studies of Olanzapine.

What is Ligament sprain?

Ligament sprain (ligament stretched) is found to be associated with 965 drugs and 812 conditions by eHealthMe. Check the latest studies of Ligament sprain.

On Jul, 14, 2026

68,588 people reported to have side effects when taking Olanzapine.
Among them, 14 people (0.02%) have Ligament sprain.

Among these 14 people:

How long have people been on Olanzapine when they have Ligament sprain? *

What is the gender of people who have Ligament sprain when taking Olanzapine? *

female: 77.78 %
male: 22.22 %

What is the age of people who have Ligament sprain when taking Olanzapine? *

What are other drugs people take besides Olanzapine? *

What are other side effects people have besides Ligament sprain? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 8 people, 57.14%
Fall: 4 people, 28.57%
Muscle Rupture (tear in muscle): 4 people, 28.57%
Nerve Injury: 4 people, 28.57%
Hallucinations (sensations that appear real but are created by your mind): 3 people, 21.43%
Weakness: 2 people, 14.29%
Road Traffic Accident: 2 people, 14.29%
Joint Swelling: 2 people, 14.29%
Ligament Disorder (disease of ligament): 2 people, 14.29%
Dizziness: 2 people, 14.29%

What are the existing conditions these people have? *

Psychotic Disorder: 2 people, 14.29%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 14.29%
Hallucinations (sensations that appear real but are created by your mind): 2 people, 14.29%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 14.29%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 7.14%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 7.14%
Portopulmonary Hypertension (coexistence of portal and pulmonary hypertension): 1 person, 7.14%
Insomnia (sleeplessness): 1 person, 7.14%
Hiv Infection: 1 person, 7.14%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Olanzapine and have Ligament sprain?

- Check whether Ligament sprain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Olanzapine:

Olanzapine (69,242 reports)

Ligament sprain treatments and more:

Ligament sprain (13,522 reports)

Browse all side effects of Olanzapine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ligament sprain:

Ligament sprain (965 drugs)

Browse all the conditions that are associated with Ligament sprain:

Ligament sprain (812 conditions)

Related publications that referenced our studies

Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on olanzapine (the active ingredients of Olanzapine) and Olanzapine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.